Effect of Shock Wave Therapy With Core Stability Exercises for Treatment of Chronic Non-Specific Back Pain (ESW)
A Randomized Controlled Trial Investigating the Effect of Extracorporeal Shock Wave Therapy With Core Stability Exercises for Treatment of Chronic Non-Specific Back Pain in Jordanian University Students
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic non-specific back pain (CNSLBP) is a prevalent condition with multifactorial causes, often linked to muscular weakness, poor postural control, and soft tissue dysfunction. Extracorporeal Shock Wave Therapy (ESWT) and core stabilization exercises (CSEs) have emerged as effective, complementary, and non-invasive treatment modalities for managing this condition.
ESWT works by delivering high-energy acoustic waves to affected tissues, stimulating biological responses such as neovascularization, collagen synthesis, and reduction of inflammation and pain mediators. These effects help improve tissue healing, decrease muscle tension, and enhance local blood flow, ultimately reducing pain intensity and improving mobility.
On the other hand, CSEs target the deep stabilizing muscles of the spine-particularly the transversus abdominis, multifidus, and pelvic floor muscles-to restore spinal stability and improve posture, balance, and functional movement. Regular performance of these exercises strengthens the core, reduces mechanical stress on the lumbar structures, and prevents pain recurrence.
When combined, ESWT and CSEs provide synergistic benefits: ESWT offers rapid pain relief and tissue recovery, facilitating better participation in exercise programs, while CSEs ensure long-term spinal stability and functional improvement. Together, they form a comprehensive and evidence-based approach to reducing pain, enhancing physical function, and improving quality of life in individuals with chronic non-specific low back pain.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mohamed AM Abo El Ros, Ph.D
- Phone Number: 01206530584
- Email: mohamed.aboelros@pt.ninu.edu.eg
Study Contact Backup
- Name: Kerolos I Kelini, Ph.D
- Phone Number: 01229712126
- Email: 3530@zuj.edu.jo
Study Locations
-
-
-
Ismailia, Egypt, 8332601
- Recruiting
- Mohamed Abdel Moenem Abo El Ros
-
Contact:
- Mohamed AM Abo El Ros
- Email: mohamed.aboelros@pt.ninu.edu.eg
-
Contact:
-
-
-
-
-
Amman, Jordan
- Recruiting
- Zaytona University in Jordon
-
Contact:
- Mohamed M Abo-El-Ros, Ph.D
- Phone Number: A 00960781524278
- Email: 3767@zuj.edu.jo
-
Contact:
- Kerolous I Kelini, Ph.D
- Phone Number: S 00201229712126
- Email: 3530@zuj.edu.jo
-
Principal Investigator:
- Mohamed M Abo-El-Ros, Ph.D
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- chronic non- specific back pain for more than 3 months
- teaching hours from 4 to 6 hours, 4 days per week\
- female sufferers
- Body Mass Index 20 - 22
Exclusion Criteria:
- No History of previous back surgeries
- no history of discogenic lesion
- overweight
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
will be subjected to extracorporeal shock wave therapy in addition to core stabilization exercise
|
treatment of chronic non-specific back pain by shock wave therapy combined with core stabilization exercises
Other Names:
|
|
Sham Comparator: control group
Control group will be assigned core stabilization exercises, and therapeutic ultrasound
|
treatment of chronic non-specific back pain by shock wave therapy combined with core stabilization exercises
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
back pain
Time Frame: 12 weeks
|
Measurement of pain intensity by visual analogue scale
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
physical function
Time Frame: 12 weeks
|
measuring of functional status by Oswestry Disability Questionnaire
|
12 weeks
|
|
Balance
Time Frame: 12 weeks
|
Measurement of changes in balance using the Biodex Balance system
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohamed AM Abo El Ros, Ph.D, Suez Canal University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB # 4/12/2024- 2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.